DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
“Agriculture” × ‘Decarbonization’ with the Power of Pine Resin. Arakawa Chemical Industries Launches New Material “EcoRosin(R)” on January 7th, Achieving Both Yield Improvement and CO₂ Reduction
Arakawa Chemical Industries, Ltd. (Headquarters: Chuo-ku, Osaka; President and CEO: Nobuyuki Takagi) will begin selling its biostimulant material “EcoRosin®,” which mitigates environmental stress caused by abnormal weather and other factors, on the following e-commerce sites starting January 7, 2026. This product leverages the company's approximately 150 years of research into pine resin.
Lifeway Foods Applauds New Federal Dietary Guidelines Highlighting Protein, Full-Fat Dairy and Fermented Foods Like Kefir
Lifeway Foods, Inc. (Nasdaq: LWAY), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, today welcomed the release of the 2025–2030 Dietary Guidelines for Americans. These new guidelines endorse full-fat dairy and highlight fermented foods, specially calling out kefir for its potential role in supporting a healthy microbiome.
AI-Based Culture Control Enhances Lactic Acid Bacteria Polysaccharide Productivity Derives Optimal Conditions Using Only 11 Training Data Points
Chitose Research Institute Co., Ltd. (hereinafter referred to as Chitose), the core entity of the Chitose Group, conducted joint research with Meiji Co., Ltd. (hereinafter referred to as Meiji) aimed at improving the productivity of polysaccharides produced by lactic acid bacteria. In this study, Chitose optimized cultivation conditions using its AI cultivation technology. With only 11 batches of training data, it succeeded in increasing polysaccharide productivity by approximately 20% compared to the initial conditions.
“The microbiome is reshaping beauty,” says Marie Drago, founder of Gallinée
Launched in London in 2016, Gallinée will celebrate its tenth anniversary next year. In under a decade, the brand has become a leading reference in microbiome-friendly skincare. A true pioneer, Gallinée helped reveal the benefits of bacteria for skin health, opening up an entirely new realm of exploration in cosmetics. Since its acquisition by Shiseido in 2022, the brand has continued to grow in a more structured way—yet remains driven by the same passion for research and innovation.
CRISPR gene editing therapy cuts high cholesterol in half
Suisu no baiotekunorojī kigyō Crispr Therapeutics ga, 15-ri no chiken sankasha o taishō ni rinshō shiken o jisshi. Kenkyū chīmu wa, CRISPR o tsukatte kanzō no shishitsu taisha o ninau `ANGPTL 3' to iu idenshi no hataraki o “teishi” sa seru chiryō o, 1-kai no tenteki de tōyo shita. Kono idenshi ni umaretsuki hen'i ga atte kinō shite inai hito wa LDL koresuterōru ya chūsei shibō ga hikuku, kokoro shikkan no risuku mo chīsai koto ga shira rete ori, akirakana kenkōjō no mondai wa mi rarenai. Konkai no chiken wa, kōshita idenshi no hataraki ga shizen ni tomatte iru jōtai o, jinkō-teki ni saigen suru koto o mokuteki to shite ita.
さらに表示
258
Swiss biotechnology company Crispr Therapeutics conducted a clinical trial on 15 participants. The research team used CRISPR to administer a treatment via a single intravenous infusion that "stops" the activity of a gene called "ANGPTL3," which is responsible for lipid metabolism in the liver. People who are born with a congenital mutation that makes this gene non-functional are known to have low levels of LDL cholesterol and triglycerides, a low risk of heart disease, and no apparent health problems. The aim of this clinical trial was to artificially recreate the state in which this gene's activity is naturally stopped.
Innovations in Hydrogenation Technology for Pharmaceutical and Biotech Applications
Hydrogenation is an essential process in the chemical and pharmaceutical industries, enabling the modification of unsaturated organic molecules to produce stable, bioactive compounds. This reaction is pivotal for synthesizing key intermediates and active pharmaceutical ingredients (APIs), as well as producing biochemicals in various biotech applications. The field of hydrogenation technology has experienced significant advancements in recent years, particularly in reactor design, catalyst optimization, and the integration of sustainable practices. These innovations are revolutionizing the efficiency, precision, and environmental impact of hydrogenation processes in pharmaceutical and biotech production.
Innovative Medical Equipment Launches Full Headcap for Migraine and Head Pain Management
Innovative Medical Equipment, LLC (IME), maker of ThermaZone®, today announced the debut of its new Full Headcap at the American Headache Society's 2025 Scottsdale Headache Symposium in Scottsdale, Arizona. The Full Headcap expands ThermaZone's existing portfolio of specialized head pads designed to help people living with migraine and other forms of head pain more effectively manage their symptoms.
Effective relief from migraine and head pain is highly individualized. Pain may be localized or widespread and may respond best to either heat or cold. The new Full Headcap features ThermaZone's proprietary Motion Advantage™ water-flow technology, which directs precisely controlled heat or cold therapy to key regions of the head, including the forehead, temples, occipital area, and cranial surface.
Hair-related molecules specifically reduced in AGA identified Confirmed in both hair shaft proteome analysis and cultured cells
Aderans Co., Ltd. (Headquarters: Shinagawa-ku, Tokyo; President and CEO: Hiroshi Suzuki), a global wellness company specializing in hair, beauty, health, and medical services, has discovered a significant reduction in hair-related molecules WNT-LESS (WLS) and WNT3 in the hair shafts (the part of the hair exposed above the skin) of the vertex region in male pattern hair loss (AGA). When dihydrotestosterone (DHT), the primary causative agent of AGA, was added to cultured cells, gene expression of WLS and WNT family members was similarly reduced. Part of these findings was presented at the 48th Annual Meeting of the Molecular Biology Society of Japan, held at the Yokohama International Peace Convention Center (Yokohama City, Kanagawa Prefecture) from Wednesday, December 3 to Friday, December 5.
Bio-sensor system developed that measures sweat lactate simply by attaching to skin—obtains medical device manufacturing and sales approval, offering new hope for exercise therapy in heart disease patients—
Yoshiki Katsumata, Assistant Professor at the Keio University School of Medicine Sports Medicine Center (Professor: Kazuki Sato), and Yasunori Shiraishi, Assistant Professor at the Department of Internal Medicine (Cardiology) (Professor: Maki Ieda), in collaboration with Grace Imaging Inc. (CEO: Daisuke Nakajima), developed a sweat lactate sensor capable of continuously monitoring lactate levels in sweat. In 2022, they conducted a physician-initiated clinical trial (Reference 1: Clinical Trial Protocol Number LacS-001; jRCT2032220057). This trial evaluated the performance of the sweat lactate sensor in estimating the anaerobic threshold (AT: a key indicator for exercise prescription in cardiac rehabilitation) in patients with heart disease and achieved its primary endpoint. Based on these trial results, we submitted an application for medical device approval for a system using the sweat lactate sensor to estimate AT. On December 3, 2025, approval for manufacturing and marketing of the medical device was granted.
Successful Hydrogen Production at Ammonia Cracking Pilot Plant Using Steam Heating Method
三菱重工業は、独自のアンモニア分解システム（注1）の開発に関して、当社総合研究所長崎地区に設置したパイロットプラントにおいて、このたび、蒸気を加熱源として利用することによって、原料のアンモニアを分解し、純度99％の水素を製造することに成功しました。蒸気加熱方式によるパイロットスケールでの水素製造は世界で初めて（注2）となります。
当社の蒸気・排ガス加熱方式は、バーナー燃焼熱を用いる従来の技術に比べ、低い反応温度でのシステムの運転を可能にするため、運転コストを削減できます。加えて、燃焼炉が不要なため、システムの小型化を実現できるなど、優れた特徴を有しています。
脱炭素社会の実現に向け、燃焼してもCO2を排出しない燃料である水素の利活用は、世界的に拡大しています。中でもアンモニアは、水素を安全かつ大量に長距離輸送・貯蔵できる「水素キャリア」として注目されています。
当社は、今回の成果を生かし、アンモニアを水素キャリアとする水素サプライチェーンの構築に向け、水素需要地の近くに設置可能な中規模・分散型アンモニア分解システムの開発を推進します。また、このパイロット試験の結果を踏まえ、国立研究開発法人新エネルギー・産業技術総合開発機構（NEDO）に採択された事業（注3）における開発を、株式会社日本触媒、北海道電力株式会社と協同で加速します。これらによって、脱炭素技術の早期確立・社会実装を図るとともに、持続可能なカーボンニュートラル社会の実現に貢献していきます。
A Study on the Discovery of Gut Bacteria Characteristic of Underweight Young Japanese Women
Professor Katsumi Iizuka of the Department of Clinical Nutrition, School of Medicine, Fujita Health University (Toyoake City, Aichi Prefecture) and Symbiosis Solutions Inc. (Headquarters: Chiyoda Ward, Tokyo) conducted a joint study comparing dietary diversity and gut microbial diversity in women aged 20-39 years (80 participants total), divided into underweight and normal weight groups. Regarding dietary surveys, no significant differences were observed between the underweight and normal-weight groups in terms of energy intake, nutrients, or dietary diversity. However, the underweight group exhibited lower gut microbiota diversity and a higher abundance of bacteria associated with inflammation compared to the normal-weight group. Dietary therapy targeting the gut microbiota may alter the intestinal environment and potentially improve underweight conditions.
‘Science-Backed’ Oral Care Brand ToothScience Launches Out of Dallas
Founded by Sulman Ahmed, the founder and CEO of Dallas-based DECA Dental Group, ToothScience aims to be "the first shot across the bow of a dentist-led revolution in whole mouth health." Its toothpaste products are "naturally flavored, dye-free, alcohol-free, gluten-free, paraben-free, cruelty-free, and non-GMO."
Bifidobacteria in Oil: A Convenient Liquid Probiotic Supplement
・Newly launched on the Naturecan official website: Bifiora lactic acid bacteria oil ・Get your bifidobacteria in oil form! A new liquid-type probiotic supplement ・Features Bifidobacterium BB536 that ‘reaches the gut alive’ ・Unscented and tasteless for easy, refreshing daily support